Cargando…
Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism
Non-alcoholic fatty liver disease (NAFLD) is a liver disease syndrome. The prevalence of NAFLD has continued to increase globally, and NAFLD has become a worldwide public health problem. Glucosamine (GLC) is an amino monosaccharide derivative of glucose. GLC has been proven to not only be effective...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574579/ https://www.ncbi.nlm.nih.gov/pubmed/37836761 http://dx.doi.org/10.3390/molecules28196918 |
_version_ | 1785120725589295104 |
---|---|
author | Li, Feng Zhang, Zhengyan Bai, Yan Che, Qishi Cao, Hua Guo, Jiao Su, Zhengquan |
author_facet | Li, Feng Zhang, Zhengyan Bai, Yan Che, Qishi Cao, Hua Guo, Jiao Su, Zhengquan |
author_sort | Li, Feng |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is a liver disease syndrome. The prevalence of NAFLD has continued to increase globally, and NAFLD has become a worldwide public health problem. Glucosamine (GLC) is an amino monosaccharide derivative of glucose. GLC has been proven to not only be effective in anti-inflammation applications, but also to modulate the gut microbiota effectively. Therefore, in this study, the therapeutic effect of GLC in the NAFLD context and the mechanisms underlying these effects were explored. Specifically, an NAFLD model was established by feeding mice a high-fat and high-sugar diet (HFHSD), and the HFHSD-fed NAFLD mice were treated with GLC. First, we investigated the effect of treating NAFLD mice with GLC by analyzing serum- and liver-related indicator levels. We found that GLC attenuated insulin resistance and inflammation, increased antioxidant function, and attenuated serum and liver lipid metabolism in the mice. Then, we investigated the mechanism underlying liver lipid metabolism, inflammation, and intestinal barrier function in these mice. We found that GLC can improve liver lipid metabolism and relieve insulin resistance and oxidative stress levels. In addition, GLC treatment increased intestinal barrier function, reduced LPS translocation, and reduced liver inflammation by inhibiting the activation of the LPS/TLR4/NF-κB pathway, thereby effectively ameliorating liver lesions in NAFLD mice. |
format | Online Article Text |
id | pubmed-10574579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105745792023-10-14 Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism Li, Feng Zhang, Zhengyan Bai, Yan Che, Qishi Cao, Hua Guo, Jiao Su, Zhengquan Molecules Article Non-alcoholic fatty liver disease (NAFLD) is a liver disease syndrome. The prevalence of NAFLD has continued to increase globally, and NAFLD has become a worldwide public health problem. Glucosamine (GLC) is an amino monosaccharide derivative of glucose. GLC has been proven to not only be effective in anti-inflammation applications, but also to modulate the gut microbiota effectively. Therefore, in this study, the therapeutic effect of GLC in the NAFLD context and the mechanisms underlying these effects were explored. Specifically, an NAFLD model was established by feeding mice a high-fat and high-sugar diet (HFHSD), and the HFHSD-fed NAFLD mice were treated with GLC. First, we investigated the effect of treating NAFLD mice with GLC by analyzing serum- and liver-related indicator levels. We found that GLC attenuated insulin resistance and inflammation, increased antioxidant function, and attenuated serum and liver lipid metabolism in the mice. Then, we investigated the mechanism underlying liver lipid metabolism, inflammation, and intestinal barrier function in these mice. We found that GLC can improve liver lipid metabolism and relieve insulin resistance and oxidative stress levels. In addition, GLC treatment increased intestinal barrier function, reduced LPS translocation, and reduced liver inflammation by inhibiting the activation of the LPS/TLR4/NF-κB pathway, thereby effectively ameliorating liver lesions in NAFLD mice. MDPI 2023-10-03 /pmc/articles/PMC10574579/ /pubmed/37836761 http://dx.doi.org/10.3390/molecules28196918 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Feng Zhang, Zhengyan Bai, Yan Che, Qishi Cao, Hua Guo, Jiao Su, Zhengquan Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism |
title | Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism |
title_full | Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism |
title_fullStr | Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism |
title_full_unstemmed | Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism |
title_short | Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism |
title_sort | glucosamine improves non-alcoholic fatty liver disease induced by high-fat and high-sugar diet through regulating intestinal barrier function, liver inflammation, and lipid metabolism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574579/ https://www.ncbi.nlm.nih.gov/pubmed/37836761 http://dx.doi.org/10.3390/molecules28196918 |
work_keys_str_mv | AT lifeng glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism AT zhangzhengyan glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism AT baiyan glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism AT cheqishi glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism AT caohua glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism AT guojiao glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism AT suzhengquan glucosamineimprovesnonalcoholicfattyliverdiseaseinducedbyhighfatandhighsugardietthroughregulatingintestinalbarrierfunctionliverinflammationandlipidmetabolism |